Encompass Health (EHC)
(Delayed Data from NYSE)
$92.65 USD
+0.59 (0.64%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $92.69 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Cash flow Statements
Fiscal Year End for Encompass Health Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 463.00 | 365.90 | 517.20 | 368.80 | 445.80 |
Depreciation/Amortization & Depletion | 283.40 | 253.30 | 264.40 | 250.20 | 223.20 |
Net Change from Assets/Liabilities | 50.30 | -30.40 | -118.00 | -7.30 | -180.10 |
Net Cash from Discontinued Operations | -4.00 | 37.10 | -0.10 | -0.20 | -3.80 |
Other Operating Activities | 58.10 | 79.90 | 52.30 | 93.20 | 150.20 |
Net Cash From Operating Activities | 850.80 | 705.80 | 715.80 | 704.70 | 635.30 |
Property & Equipment | -583.10 | -574.00 | -544.70 | -404.70 | -385.40 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -118.60 | -1.10 | -231.50 |
Investments | -23.00 | -35.20 | -9.00 | -8.70 | -32.90 |
Other Investing Activities | 3.30 | -17.80 | 6.00 | 7.00 | -7.60 |
Net Cash from Investing Activities | -602.80 | -627.00 | -666.30 | -407.50 | -657.40 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | -6.10 | -45.90 |
Issuance (Repayment) of Debt | -83.30 | -498.20 | -66.30 | 206.70 | 476.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -60.40 | -99.00 | -112.40 | -111.90 | -108.70 |
Other Financing Activities | -53.50 | 451.50 | -61.40 | -234.60 | -273.20 |
Net Cash from Financing Activities | -197.20 | -145.70 | -240.10 | -145.90 | 48.20 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 50.80 | -66.90 | -190.60 | 151.30 | 26.10 |
Cash at Beginning of Period | 53.40 | 120.30 | 310.90 | 159.60 | 133.50 |
Cash at End of Period | 104.20 | 53.40 | 120.30 | 310.90 | 159.60 |
Diluted Net EPS | 3.47 | 2.70 | 4.11 | 2.85 | 3.61 |
Fiscal Year End for Encompass Health Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 285.30 | 138.80 | 463.00 | 343.90 | 230.50 |
Depreciation/Amortization & Depletion | 143.20 | 70.30 | 283.40 | 203.80 | 136.50 |
Net Change from Assets/Liabilities | -13.40 | -1.60 | 50.30 | 58.90 | 41.40 |
Net Cash from Discontinued Operations | -0.20 | 0.60 | -4.00 | -1.10 | -0.70 |
Other Operating Activities | 41.30 | 30.70 | 58.10 | 44.30 | 26.90 |
Net Cash From Operating Activities | 456.20 | 238.80 | 850.80 | 649.80 | 434.60 |
Property & Equipment | -296.30 | -139.40 | -583.10 | -360.50 | -213.80 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | -23.00 | -21.10 | 0.00 |
Other Investing Activities | 8.20 | 9.70 | 3.30 | -13.10 | -18.70 |
Net Cash from Investing Activities | -288.10 | -129.70 | -602.80 | -394.70 | -232.50 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -16.80 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | -13.10 | -1.00 | -83.30 | -77.20 | -50.20 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -30.80 | -15.90 | -60.40 | -45.50 | -30.50 |
Other Financing Activities | -29.50 | -23.70 | -53.50 | -44.60 | -20.80 |
Net Cash from Financing Activities | -90.20 | -40.60 | -197.20 | -167.30 | -101.50 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 77.90 | 68.50 | 50.80 | 87.80 | 100.60 |
Cash at Beginning of Period | 104.20 | 104.20 | 53.40 | 53.40 | 53.40 |
Cash at End of Period | 182.10 | 172.70 | 104.20 | 141.20 | 154.00 |
Diluted Net EPS | 1.12 | 1.10 | 0.86 | 0.84 | 0.90 |